| 11124496 |
Imidazolidine compounds |
Lian Zhu Liu, Xiaoqing Wang |
2021-09-21 |
$354,607,000 |
| 10053429 |
DGAT2 inhibitors |
Ana Maria Escribano, Maria Rosario Gonzalez, Celia Lafuente Blanco, Maria Dolores Martin-Ortega Finger |
2018-08-21 |
$399,569,000 |
| 9206139 |
Aggrecanase inhibitors |
Timothy Barrett Durham, Jothirajah MARIMUTHU |
2015-12-08 |
$509,061,000 |
| 8133907 |
Pyridine derivatives as dipeptedyl peptidase inhibitors |
Larry C. Blaszczak, Brian Michael Mathes, Shon Pulley, Michael Alan Robertson, Scott Martin Sheehan +2 more |
2012-03-13 |
$193,239,000 |
| 8106090 |
1-amino linked compounds |
Larry C. Blaszczak, Shon Pulley, Michael Alan Robertson, Scott Martin Sheehan, Qing Shi |
2012-01-31 |
$97,135,000 |
| 8076514 |
Phenyl compounds and their use in the treatment of Type II diabetes |
Larry C. Blaszczak, Shon Pulley, Michael Alan Robertson, Scott Martin Sheehan, Qing Shi +1 more |
2011-12-13 |
$77,945,000 |
| 7700628 |
Aromatic ether derivatives useful as thrombin inhibitors |
Ankush Argade, Theodore Goodson, Jr., David Kent Herron, Sajan Joseph, Salvatore D. Lepore +8 more |
2010-04-20 |
$177,396,000 |
| 7666866 |
Antithrombotic diamides |
Jeffry Bernard Franciskovich, David Kent Herron, Valentine Joseph Klimkowski, Angela Lynn Marquart, John Joseph Masters +4 more |
2010-02-23 |
$69,186,000 |
| 7615568 |
Antithrombotic ethers |
Jeffry Bernard Franciskovich, David Kent Herron, Jared Harris Linebarger, Angela Lynn Marquart, John Joseph Masters +6 more |
2009-11-10 |
$126,664,000 |
| 7511066 |
Antithrombotic aromatic ethers |
Jeffry Bernard Franciskovich, Theodore Goodson, Jr., David Kent Herron, Angela Lynn Marquart, John Joseph Masters +5 more |
2009-03-31 |
$80,339,000 |
| 7449457 |
Substituted heterocyclic carboxamides with antithrombotic activity |
David Kent Herron, Sajan Joseph, Angela Lynn Marquart, John Joseph Masters, David Mendel +4 more |
2008-11-11 |
$124,430,000 |
| 7351822 |
Serine protease inhibitors |
John Walter Liebeschuetz, Christopher William Murray, Stephen Young, Nicholas Paul Camp, Stuart Donald Jones +7 more |
2008-04-01 |
$77,622,000 |
| 7297706 |
Certain glycine derivatives as factor Xa inhibitors for use in the treatment of thrombotic disorders |
Daniel Jon Sall, Christopher William Murray, Stephen Young, Jolie Anne Bastian |
2007-11-20 |
$175,995,000 |
| 7294627 |
Chemical compounds |
Steven Douglas Hiscock, Stuart Donald Jones, Daniel Jon Sall, Stephen Young |
2007-11-13 |
$94,713,000 |
| 7265121 |
Chemical compounds |
Daniel Jon Sall, John Walter Liebeschuetz |
2007-09-04 |
$45,006,000 |
| 7166606 |
Certain 1-(D-cycloproplyglycinyl)-4-piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor Xa |
Gary Lowell Engel |
2007-01-23 |
$182,925,000 |
| 7163938 |
Substituted carboxamides |
David Kent Herron, Sajan Joseph, Angela Lynn Marquart, John Joseph Masters, David Mendel +3 more |
2007-01-16 |
$95,135,000 |
| 7160878 |
Substituted heterocyclic amides |
David Kent Herron, Sajan Joseph, Angela Lynn Marquart, John Joseph Masters, David Mendel +3 more |
2007-01-09 |
$58,894,000 |
| 7129245 |
Aromatic amides |
Douglas Wade Beight, Trelia Joyce Craft, Carl Penman Denny, Jeffry Bernard Franciskovich, Theodore Goodson, Jr. +17 more |
2006-10-31 |
$214,819,000 |
| 7115609 |
Alanyl-piperidine heterocyclic derivatives useful against cardiovascular diseases |
Stuart Donald Jones, Daniel Jon Sall |
2006-10-03 |
$111,542,000 |
| 7078415 |
Certain glycine derivatives as factor Xa inhibitors for use in the treatment of thrombotic disorders |
Daniel Jon Sall, Christopher William Murray, Stephen Young, Jolie Anne Bastian |
2006-07-18 |
$239,286,000 |
| 7053078 |
Serine protease inhibitors |
John Walter Liebeschuetz, Christopher William Murray, Stephen Young, Nicholas Paul Camp, Stuart Donald Jones +5 more |
2006-05-30 |
$99,833,000 |
| 6946467 |
Serine protease inhibitors |
John Walter Liebeschuetz, Christopher William Murray, Stephen Young, Nicholas Paul Camp, Stuart Donald Jones +7 more |
2005-09-20 |
$151,668,000 |
| 6936611 |
Serine protease inhibitors |
John Walter Liebeschuetz, Christopher William Murray, Stephen Young, Nicholas Paul Camp, Stuart Donald Jones +7 more |
2005-08-30 |
$148,835,000 |
| 6924296 |
Antithrombotic agents |
Douglas Wade Beight, John Joseph Masters, Jason Scott Sawyer, Robert T. Shuman, Ying Kwong Yee |
2005-08-02 |
$141,427,000 |
